Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials
Health Canada’s Therapeutic Products Directorate (TPD) and Biologics and Genetic Therapies Directorate (BGTD) are responsible for reviewing the applications for authorization to sell or import drugs for the purposes of conducting clinical trials in Canada.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trialsHTMLEnglish publication HTML
Similar records